Citations

Clear

75 citation(s) found for "Starlinger, P".

Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery
Starlinger, Patrick , Pereyra, David , Hackl, Hubert , Ortmayr, Gregor , Braunwarth, Eva , Santol, Jonas , Najarnia, S. , Driedger, Michael R. , Gregory, Lindsey A., Alva‐Ruiz, Roberto, Glasgow, Amy E. , Assinger, Alice , Nagorney, David M. , Habermann, Elizabeth B. , Staetttner, Stefan, Smoot, Rory L. , Glasgow, Amy E. , Gregory, Lindsey, Glasgow, Amy, Cleary, Sean P. , Maier, Eva , Smoot, Rory L , Habermann, Elizabeth , Pereyra, David , Assinger, Alice , Starlinger, Patrick , Hackl, Hubert , Glasgow, Amy E , Santol, Jonas , Gruenberger, Thomas

Mayo Clinic

Hepatology | October 20, 2020 | Volume: 73 | Issue: 5 | Pages: 1956-1966

10.1002/hep.31601 | PMID 33078426 Get It

Background and Aims Platelet‐stored serotonin critically affects liver regeneration in mice and humans. Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitors (SNRIs) reduce intraplatelet serotonin. As SSRIs/SNRIs are now one of the most commonly prescribed drugs in the United States and Europe and given serotonin’s impact on liver regeneration, we evaluated whether perioperative use of SSRIs/SNRIs affects outcome after hepatic resection. Approach and Results Consecutive patients undergoing hepatic resection (n = 754) were retrospectively included from prospectively maintained databases from two European institutions. Further, an independent cohort of 495 patients from the United States was assessed to validate our exploratory findings. Perioperative intake of SSRIs/SNRIs was recorded, and patients were followed up for postoperative liver dysfunction (LD), morbidity, and mortality. Perioperative intraplatelet serotonin levels were significantly decreased in patients receiving SSRI/SNRI treatment. Patients treated with SSRIs/SNRIs showed a higher incidence of morbidity, severe morbidity, LD, and LD requiring intervention. Associations were confirmed in the independent validation cohort. Combined cohorts documented a significant increase in deleterious postoperative outcome (morbidity odds ratio [OR], 1.56; 95% confidence interval [CI], 1.07‐2.31; severe morbidity OR, 1.86; 95% CI, 1.22‐2.79; LD OR, 1.96; 95% CI, 1.23‐3.06; LD requiring intervention OR, 2.22; 95% CI, 1.03‐4.36). Further, multivariable analysis confirmed the independent association of SSRIs/SNRIs with postoperative LD, which was closely associated with postoperative 90‐day mortality and 1‐year overall survival. Conclusions We observed a significant association of perioperative SSRI/SNRI intake with adverse postoperative outcome after hepatic resection. This indicates that SSRIs/SNRIs should be avoided perioperatively in patients undergoing hepatic resections.
Carpal Tunnel Syndrome Treatment and the Subsequent Alterations in Median Nerve Transverse Mobility
Hosseini‐Farid, Mohammad , Schrier, Verena J.M.M. , Amadio, Peter C. , Starlinger, Julia , Amadio, Peter C

Mayo Clinic

Journal of Ultrasound in Medicine | October 19, 2020 | Volume: 40 | Issue: 8 | Pages: 1555-1568

10.1002/jum.15535 | PMID 33073880 Get It

ObjectivesThe mobility (transverse movement) of the median nerve (MN) is decreased in patients with carpal tunnel syndrome and can be measured noninvasively by ultrasound. To date, there are few prognostic features to help predict the outcome of 2 commonly performed treatments: surgical carpal tunnel release and corticosteroid injection. This study aimed to assess the changes in nerve mobility after the intervention and to correlate this with treatment and the disease severity.MethodsA total of 181 patients with carpal tunnel syndrome with different electrophysiologic severities were recruited and assessed by dynamic ultrasound scanning of the MN before and after treatment. The dynamic ultrasound images were collected while the patients performed finger and wrist flexion.ResultsFor both injection and carpal tunnel release, the nerve displacement increased with wrist flexion, from a mean ± SD of 7.0 ± 2.4 to 7.9 ± 2.7 mm (P < .005). Patients who underwent surgery showed greater improvement (P < .005) in nerve mobility compared to those who underwent injection. We also observed that the increase in nerve mobility was predominantly in patients with more nerve damage at baseline.ConclusionsThis study shows that the dynamic behavior of the MN changes in response to treatment and lays a foundation for future studies to assess the prognostic potential of nerve mobility measurement.
A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses
Stary, Victoria , Pandey, Ram Vinay , Strobl, Johanna , Kleißl, Lisa , Pereyra, David , Fischer, Gottfried , Bock, Christoph , Farlik, Matthias , Stary, Georg , Pereyra, David , Fischer, Gottfried F , Bock, Christoph , Farlik, Matthias , Stary, Georg , Strobl, Johanna , Starlinger, Patrick , Weninger, Wolfgang

Mayo Clinic

Science Immunology | October 16, 2020 | Volume: 5 | Issue: 52 | Pages: No page available

10.1126/sciimmunol.aba6232 | PMID 33067380 Get It

CD49a + CD16 − NK cells from the liver and contact dermatitis lesions specifically recognize antigens and contribute to adaptive immunity.
Hemostasis and Liver Regeneration
Luyendyk, James P. , Groeneveld, Dafna J. , Luyendyk, James P , Starlinger, Patrick

Mayo Clinic

Seminars in Thrombosis and Hemostasis | September 9, 2020 | Volume: 46 | Issue: 06 | Pages: 735-742

10.1055/s-0040-1715450 | PMID 32906177 Get It

AbstractThe liver is unique in its remarkable regenerative capacity, which enables the use of liver resection as a treatment for specific liver diseases, including removal of neoplastic liver disease. After resection, the remaining liver tissue (i.e, liver remnant) regenerates to maintain normal hepatic function. In experimental settings as well as patients, removal of up to two-thirds of the liver mass stimulates a rapid and highly coordinated process resulting in the regeneration of the remaining liver. Mechanisms controlling the initiation and termination of regeneration continue to be discovered, and many of the fundamental signaling pathways controlling the proliferation of liver parenchymal cells (i.e., hepatocytes) have been uncovered. Interestingly, while hemostatic complications (i.e., bleeding and thrombosis) are primarily thought of as a complication of surgery itself, strong evidence suggests that components of the hemostatic system are, in fact, powerful drivers of liver regeneration. This review focuses on the clinical and translational evidence supporting a link between the hemostatic system and liver regeneration, and the mechanisms whereby the hemostatic system directs liver regeneration discovered using experimental settings.
RE: Aliuskevicius M, Ostgaard SE, Hauge EM, et al. 2019. Influence of ibuprofen on bone healing after Colles’ fracture: A randomized controlled clinical trial
Starlinger, Julia , Amadio, Peter C. , Balls-Berry, Joyce, Amadio, Peter C , Balls‐Berry, Joyce E.

Mayo Clinic

Journal of Orthopaedic Research | January 10, 2020 | Volume: 38 | Issue: 6 | Pages: 1204-1205

10.1002/jor.24582 | PMID 31919898 Get It